173 related articles for article (PubMed ID: 32794230)
1. Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Brady SL; Woodward AP; le Chevoir M
Aust Vet J; 2020 Oct; 98(10):491-498. PubMed ID: 32794230
[TBL] [Abstract][Full Text] [Related]
2. Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown aetiology in dogs.
Adamo PF; Rylander H; Adams WM
J Small Anim Pract; 2007 Sep; 48(9):486-96. PubMed ID: 17617166
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009-2017).
Song JH; Yu DH; Lee HC; Hwang TS; Kim YJ; An SJ; Jung DI
BMC Vet Res; 2020 Jun; 16(1):192. PubMed ID: 32532259
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review.
Cornelis I; Van Ham L; Gielen I; De Decker S; Bhatti SFM
Vet J; 2019 Feb; 244():37-44. PubMed ID: 30825893
[TBL] [Abstract][Full Text] [Related]
5. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol.
Lowrie M; Smith PM; Garosi L
Vet Rec; 2013 May; 172(20):527. PubMed ID: 23462382
[TBL] [Abstract][Full Text] [Related]
6. Long-term immunosuppressive therapy with cyclosporine plus prednisolone for necrotizing meningoencephalitis in a Pekingese dog.
Jung DI; Kim JW; Park HM
J Vet Med Sci; 2012 Jun; 74(6):765-9. PubMed ID: 22214856
[TBL] [Abstract][Full Text] [Related]
7. Ciclosporin treatment of suspected granulomatous meningoencephalomyelitis in three dogs.
Gnirs K
J Small Anim Pract; 2006 Apr; 47(4):201-6. PubMed ID: 16573763
[TBL] [Abstract][Full Text] [Related]
8. A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool.
Beckmann K; Carrera I; Steffen F; Golini L; Kircher PR; Schneider U; Bley CR
Acta Vet Scand; 2015 Jan; 57(1):4. PubMed ID: 25637270
[TBL] [Abstract][Full Text] [Related]
9. Clinical Presentation, Diagnostic Findings, and Long-term Survival Time in 182 Dogs With Meningoencephalitis of Unknown Origin From Central Europe That Were Administered Glucocorticosteroid Monotherapy.
Paušová TK; Tomek A; Šrenk P; Belašková S
Top Companion Anim Med; 2021 Aug; 44():100539. PubMed ID: 33964477
[TBL] [Abstract][Full Text] [Related]
10. Investigation of side effects to treatment and cause of death in 63 Scandinavian dogs suffering from meningoencephalitis of unknown origin: a retrospective study.
Heidemann PL; Erhald B; Koch BC; Gredal H
Acta Vet Scand; 2023 Oct; 65(1):46. PubMed ID: 37858113
[TBL] [Abstract][Full Text] [Related]
11. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.
Menaut P; Landart J; Behr S; Lanore D; Trumel C
Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and blood lactate concentrations as prognostic biomarkers in dogs with meningoencephalitis of unknown origin.
Portero M; Martínez de Merlo E; Pérez C; Benito M; Daza MA; Fragio C
Vet J; 2019 Dec; 254():105395. PubMed ID: 31836169
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin.
Lawn RW; Harcourt-Brown TR
Vet J; 2022 Sep; 287():105884. PubMed ID: 35987308
[TBL] [Abstract][Full Text] [Related]
14. Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin.
Lowrie M; Thomson S; Smith P; Garosi L
Vet J; 2016 Jul; 213():1-5. PubMed ID: 27240905
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid monotherapy versus combined cytarabine continuous rate infusion and corticosteroid therapy in dogs with meningoencephalitis of unknown origin: A blinded, randomized, controlled trial.
Jones BS; Liebel FX; Fadda A; Martin S; Lawn R; Lazzerini K; Harcourt-Brown T
J Vet Intern Med; 2024; 38(3):1618-1625. PubMed ID: 38700360
[TBL] [Abstract][Full Text] [Related]
16. Unsuccessful cyclosporine plus prednisolone therapy for autoimmune meningoencephalitis in three dogs.
Jung DI; Lee HC; Ha J; Jung HW; Jeon JH; Moon JH; Lee JH; Kim NH; Sur JH; Kang BT; Cho KW
J Vet Med Sci; 2013 Dec; 75(12):1661-5. PubMed ID: 23955394
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability.
Gonçalves R; De Decker S; Walmsley G; Maddox TW
J Vet Intern Med; 2024; 38(3):1583-1590. PubMed ID: 38483069
[TBL] [Abstract][Full Text] [Related]
18. Improved survival time in dogs with suspected GME treated with ciclosporin.
Pakozdy A; Leschnik M; Kneissl S; Gumpenberger M; Gruber A; Tichy A; Thalhammer JG
Vet Rec; 2009 Jan; 164(3):89-90. PubMed ID: 19151407
[No Abstract] [Full Text] [Related]
19. Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology.
Cornelis I; Volk HA; Van Ham L; De Decker S
Vet J; 2016 Aug; 214():91-5. PubMed ID: 27387733
[TBL] [Abstract][Full Text] [Related]
20. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
